121 related articles for article (PubMed ID: 21716249)
1. [The experience of using the atypical antipsychotic sertindole in psychiatric inpatient clinics in Russia].
Ivanets NN; Kinkul'kina MA; Avdeeva TI
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(6):37-41. PubMed ID: 21716249
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of patients on sertindole treatment after failure of other antipsychotics: a retrospective analysis.
Azorin JM; Murteira S; Hansen K; Toumi M
BMC Psychiatry; 2008 Mar; 8():16. PubMed ID: 18366634
[TBL] [Abstract][Full Text] [Related]
3. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
[TBL] [Abstract][Full Text] [Related]
4. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
Gallhofer B; Jaanson P; Mittoux A; Tanghøj P; Lis S; Krieger S
Pharmacopsychiatry; 2007 Nov; 40(6):275-86. PubMed ID: 18030652
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
Daniel DG; Wozniak P; Mack RJ; McCarthy BG
Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200
[TBL] [Abstract][Full Text] [Related]
6. Sertindole in the long-term treatment of schizophrenia.
Hale AS; Azorin JM; Lemming OM; Mæhlum E
Int Clin Psychopharmacol; 2012 Jul; 27(4):231-7. PubMed ID: 22609816
[TBL] [Abstract][Full Text] [Related]
7. Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP).
Thomas SH; Drici MD; Hall GC; Crocq MA; Everitt B; Lader MH; Le Jeunne C; Naber D; Priori S; Sturkenboom M; Thibaut F; Peuskens J; Mittoux A; Tanghøj P; Toumi M; Moore ND; Mann RD
Acta Psychiatr Scand; 2010 Nov; 122(5):345-55. PubMed ID: 20384598
[TBL] [Abstract][Full Text] [Related]
8. Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled study.
Nielsen J; Emborg C; Gydesen S; Dybbro J; Aagaard J; Haderup K; Glyngdal P; Fabricius S; Thode D; Lublin H; Andersen T; Damkier P; Taylor D
J Clin Psychopharmacol; 2012 Apr; 32(2):173-8. PubMed ID: 22367659
[TBL] [Abstract][Full Text] [Related]
9. Ejaculatory dysfunction in patient with schizophrenia on sertindole.
Jukić MK; Drmić S; Mimica N
Psychiatr Danub; 2010 Mar; 22(1):128-31. PubMed ID: 20305609
[TBL] [Abstract][Full Text] [Related]
10. The atypical antipsychotic sertindole: a case series.
Lee AM; Knoll JL; Suppes T
J Clin Psychiatry; 1997 Sep; 58(9):410-6; quiz 417-8. PubMed ID: 9378698
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of sertindole in schizophrenia: a clinical review.
Zoccali RA; Bruno A; Muscatello MR
J Clin Psychopharmacol; 2015 Jun; 35(3):286-95. PubMed ID: 25830594
[TBL] [Abstract][Full Text] [Related]
12. A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia.
Azorin JM; Strub N; Loft H
Int Clin Psychopharmacol; 2006 Jan; 21(1):49-56. PubMed ID: 16317317
[TBL] [Abstract][Full Text] [Related]
13. Sertindole for the treatment of schizophrenia.
Azorin JM; Kaladjian A; Fakra E; Adida M
Expert Opin Pharmacother; 2010 Dec; 11(18):3053-64. PubMed ID: 21080854
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
Kane JM; Potkin SG; Daniel DG; Buckley PF
J Clin Psychiatry; 2011 Feb; 72(2):194-204. PubMed ID: 20673553
[TBL] [Abstract][Full Text] [Related]
15. Do we need another atypical antipsychotic?
Kasper S
Eur Neuropsychopharmacol; 2008 Aug; 18 Suppl 3():S146-52. PubMed ID: 18511242
[TBL] [Abstract][Full Text] [Related]
16. Marked elevation of creatine kinase with sertindole: a case report.
Oulis P; Koulouris GC; Konstantakopoulos G; Masdrakis VG
Pharmacopsychiatry; 2007 Nov; 40(6):295-6. PubMed ID: 18030658
[No Abstract] [Full Text] [Related]
17. Sertindole: a review of clinical efficacy.
Kane JM
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S59-63; discussion S63-4. PubMed ID: 9690972
[TBL] [Abstract][Full Text] [Related]
18. The European post-marketing observational sertindole study: an investigation of the safety of antipsychotic drug treatment.
Kasper S; Möller HJ; Hale A
Eur Arch Psychiatry Clin Neurosci; 2010 Feb; 260(1):59-68. PubMed ID: 19455275
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, cardiac safety and tolerability of sertindole: a drug surveillance.
Pezawas L; Quiner S; Moertl D; Tauscher J; Barnas C; Küfferle B; Wolf R; Kasper S
Int Clin Psychopharmacol; 2000 Jul; 15(4):207-14. PubMed ID: 10954060
[TBL] [Abstract][Full Text] [Related]
20. Medical complications and selectivity of therapeutic response to atypical antipsychotic drugs.
Perkins DO; Lieberman JA
Am J Psychiatry; 1998 Feb; 155(2):272-6. PubMed ID: 9464209
[No Abstract] [Full Text] [Related]
[Next] [New Search]
